propentofylline has been researched along with Briquet Syndrome in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was undertaken to determine whether propentofylline, a glial modulating agent, could both prevent the induction of mechanical allodynia and attenuate existing mechanical allodynia in a rodent L5 spinal nerve transection model of neuropathic pain." | 3.71 | Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. ( DeLeo, JA; Schubert, P; Sweitzer, SM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sweitzer, SM | 1 |
| Schubert, P | 1 |
| DeLeo, JA | 1 |
1 other study available for propentofylline and Briquet Syndrome
| Article | Year |
|---|---|
Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Immunohistochemistr | 2001 |